# Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea

> **NCT02132117** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 445 (actual)

## Conditions studied

- Erythema
- Rosacea

## Interventions

- **DRUG:** Oxymetazoline HCL Cream 1.0%
- **DRUG:** Vehicle to Oxymetazoline HCL Cream

## Key facts

- **NCT ID:** NCT02132117
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-04
- **Final completion:** 2015-05
- **Target enrollment:** 445 (ACTUAL)
- **Last updated:** 2019-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02132117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02132117, "Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02132117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*